Stay updated with breaking news from Accoya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coya Therapeutics (NASDAQ:COYA – Get Rating) had its price objective boosted by equities researchers at Chardan Capital from $9.00 to $11.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Chardan Capital’s target price would indicate a potential upside of 134.04% from the stock’s current price. Separately, BTIG Research started […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Rating)’s share price was up 1.1% on Monday . The stock traded as high as $5.49 and last traded at $5.30. Approximately 41,781 shares were traded during trading, an increase of 70% from the average daily volume of 24,617 shares. The stock had previously closed at $5.24. Analyst Ratings […]
HOUSTON, TX / ACCESSWIRE / April 14, 2023 / In many ways, Alzheimer's disease (AD) remains a mystery. Most common in those over 65, AD is the most common form of dementia, but its exact causes remain unclear
Coya Therapeutics (NASDAQ:COYA – Get Rating)‘s stock had its “buy” rating reaffirmed by investment analysts at Chardan Capital in a research report issued on Thursday, Benzinga reports. They presently have a $9.00 price target on the stock. Chardan Capital’s price target indicates a potential upside of 125.56% from the company’s previous close. Coya Therapeutics Trading […]
Chardan Capital restated their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $9.00 price target on the stock. Coya Therapeutics Stock Up 0.9 % Shares of COYA opened at $4.06 on Wednesday. The business’s 50-day simple moving […]